scholarly journals Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

2019 ◽  
Vol 14 (7) ◽  
pp. 1233-1243 ◽  
Author(s):  
D. Ross Camidge ◽  
Rafal Dziadziuszko ◽  
Solange Peters ◽  
Tony Mok ◽  
Johannes Noe ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Safety Data ◽  
Small Cell ◽  
Phase Iii ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Alk Positive

scholarly journals MA07.02 Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer

2017 ◽  
Vol 12 (1) ◽  
pp. S378 ◽  
Author(s):  
D. Ross Camidge ◽  
Shirish Gadgeel ◽  
Sai-Hong Ou ◽  
Leena Gandhi ◽  
Gregory Riely ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Safety Data ◽  
Small Cell ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Alk Positive

scholarly journals MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)

2017 ◽  
Vol 12 (1) ◽  
pp. S378-S379 ◽  
Author(s):  
Young Kim ◽  
Toyoaki Hida ◽  
Hiroshi Nokihara ◽  
Masashi Kondo ◽  
Koichi Azuma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Alk Positive

scholarly journals Erlotinib (ERL) versus Pemetrexed (MTA) as Second-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer (NSNSCLC): Efficacy and Safety Data

2012 ◽  
Vol 23 ◽  
pp. ix438-ix439
Author(s):  
J. Zugazagoitia ◽  
J. Puente ◽  
S. Hernandez ◽  
J.L. Gonzalez-Larriba ◽  
J. Sanz ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Safety Data ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Efficacy And Safety ◽  
Small Cell Lung

Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study

Lung Cancer ◽  
2012 ◽  
Vol 77 (2) ◽  
pp. 339-345 ◽  
Author(s):  
Yi-Long Wu ◽  
Joo-Hang Kim ◽  
Keunchil Park ◽  
Adel Zaatar ◽  
Gaëlle Klingelschmitt ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Asian Patients
Sign in / Sign up

Export Citation Format

Share Document